Fjarde AP Fonden Fourth Swedish National Pension Fund increased its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 45.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 329,484 shares of the company’s stock after acquiring an additional 103,000 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Colgate-Palmolive were worth $29,950,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Brighton Jones LLC grew its position in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Colgate-Palmolive by 14.2% during the 1st quarter. GAMMA Investing LLC now owns 11,797 shares of the company’s stock valued at $1,105,000 after buying an additional 1,468 shares during the period. Golden State Wealth Management LLC grew its holdings in shares of Colgate-Palmolive by 266.9% during the 1st quarter. Golden State Wealth Management LLC now owns 521 shares of the company’s stock valued at $49,000 after acquiring an additional 379 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Colgate-Palmolive by 9.0% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 171,983 shares of the company’s stock worth $15,963,000 after acquiring an additional 14,172 shares during the last quarter. Finally, Essex Financial Services Inc. raised its holdings in shares of Colgate-Palmolive by 1.6% during the first quarter. Essex Financial Services Inc. now owns 18,422 shares of the company’s stock worth $1,726,000 after acquiring an additional 288 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on CL. Deutsche Bank Aktiengesellschaft set a $86.00 target price on Colgate-Palmolive in a research report on Friday, October 10th. JPMorgan Chase & Co. dropped their price objective on Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. Piper Sandler started coverage on shares of Colgate-Palmolive in a research note on Friday, October 3rd. They issued a “neutral” rating and a $84.00 target price for the company. Citigroup decreased their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a research report on Monday, August 4th. Finally, The Goldman Sachs Group cut their price target on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.
Colgate-Palmolive Trading Down 0.3%
NYSE:CL opened at $77.79 on Tuesday. The company’s 50 day moving average is $81.20 and its 200-day moving average is $86.81. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12 month low of $76.68 and a 12 month high of $100.18. The firm has a market cap of $62.87 billion, a price-to-earnings ratio of 21.85, a P/E/G ratio of 4.58 and a beta of 0.34.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive’s revenue was up 1.0% compared to the same quarter last year. During the same period last year, the business posted $0.91 EPS. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. Colgate-Palmolive’s payout ratio is presently 58.43%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- Canada Bond Market Holiday: How to Invest and Trade
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- Asset Allocation Strategies in Volatile Markets
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
